Gabon vs Republic of Moldova: Access to anti-retroviral drugs, female
Gabon
63.0%
in 2024
Republic of Moldova
62.0%
in 2024
Gabon rank
96th
Republic of Moldova rank
99th
Access to anti-retroviral drugs, female over time
- Gabon
- Republic of Moldova
How they compare
Gabon currently reports 63.0% against 62.0% in Republic of Moldova, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Republic of Moldova ahead.
Gabon ranks 96th and Republic of Moldova ranks 99th of 141 countries.
Across the 3 decades both report, Gabon averaged higher in 2 and Republic of Moldova in 1.
Head to head by decade
| Decade | Gabon | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 1.4% | 5.5% | Gabon |
| 2010s | 36.7% | 27.8% | 8.9% | Gabon |
| 2020s | 53.4% | 56.4% | 3.0% | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Gabon or Republic of Moldova?
- Gabon, at 63.0% against 62.0% in Republic of Moldova as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Gabon and Republic of Moldova?
- 1.0%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Gabon and Republic of Moldova rank globally for access to anti-retroviral drugs, female?
- Gabon ranks 96th and Republic of Moldova ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.